MetaCap

Who Owns 20/20 Biolabs Stock?

NASDAQ: AIDXHealth CarePrecision InstrumentsUSD

0.375-0.004 (-1.06%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
4.23%
Institutional holders
15
  • Institutions 4.2%
  • Insiders 20.4%
  • Public and other 75.4%

Who owns 20/20 Biolabs stock?

Institutional investors own about 4.2% of 20/20 Biolabs's shares, spread across 15 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 20.40% of AIDX.

The largest institutional holders are Cresset Asset Management, LLC (1.88%), HRT Financial LP (0.70%) and Vanguard Fiduciary Trust Co (0.41%). Together, the top 10 institutions control 4.2% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their AIDX positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AIDX

20/20 Biolabs top institutional holders
InstitutionShares% HeldChange
Cresset Asset Management, LLC240.12K1.88%-9.2%
HRT Financial LP89.27K0.70%+100.0%
Vanguard Fiduciary Trust Co52.09K0.41%+100.0%
Geode Capital Management, LLC49.14K0.38%+100.0%
Atlantic Union Bankshares Corp35.10K0.27%+100.0%
Vanguard Capital Management LLC24.53K0.19%+100.0%
Citadel Advisors Llc23.20K0.18%+43.0%
Bank of America Corporation13.02K0.10%+100.0%
Susquehanna International Group, LLP10.01K0.08%+100.0%
McDonald Partners LLC2.80K0.02%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AIDX

20/20 Biolabs top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund43.82K0.34%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund5.32K0.04%

Frequently asked questions

Who is the largest shareholder of 20/20 Biolabs?

Cresset Asset Management, LLC is the largest institutional shareholder of AIDX, owning 1.88% of shares outstanding (240.12K shares) as of its latest 13F filing.

What percentage of 20/20 Biolabs is owned by institutions?

Institutions own about 4.2% of AIDX shares and 5.3% of the public float.

How much of 20/20 Biolabs do insiders own?

Insiders, such as officers and directors, own about 20.40% of AIDX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related